Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › PA › ALLENTOWN › ST. LUKE'S HOSPITAL

ST. LUKE'S HOSPITAL

NPI: 1548293954 · ALLENTOWN, PA 18104 · General Acute Care Hospital · NPI assigned 07/09/2006

$23.43M
Total Medicaid Paid
467,382
Total Claims
400,615
Beneficiaries
251
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialROSKO, ANDREA (EXECUTIVE DIRECTOR, SLPHO)
NPI Enumeration Date07/09/2006

Related Entities

Other providers sharing the same authorized official: ROSKO, ANDREA

ProviderCityStateTotal Paid
THE CARBON-SCHUYLKILL COMMUNITY HOSPITAL, INC. COALDALE PA $8.59M
THE CARBON-SCHUYLKILL COMMUNITY HOSPITAL, INC. NESQUEHONING PA $433K
ST. LUKE'S HOSPITAL BETHLEHEM PA $3K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 68 $17K
2019 7,915 $431K
2020 45,534 $2.10M
2021 161,068 $7.31M
2022 82,352 $4.55M
2023 94,319 $5.02M
2024 76,126 $4.01M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99283 Emergency department visit for the evaluation and management, moderate severity 43,704 42,218 $6.12M
99284 Emergency department visit for the evaluation and management, high severity 26,237 25,401 $4.17M
T1015 Clinic visit/encounter, all-inclusive 52,420 13,877 $1.85M
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 22,809 21,866 $1.78M
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 9,306 8,991 $1.67M
99050 9,837 9,342 $978K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 8,843 8,727 $963K
G0378 Hospital observation service, per hour 1,078 929 $930K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 7,345 7,093 $575K
99282 Emergency department visit for the evaluation and management, low to moderate severity 9,478 9,308 $498K
74177 Computed tomography, abdomen and pelvis; with contrast material 2,826 2,748 $487K
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 4,038 4,038 $403K
80053 Comprehensive metabolic panel 20,041 19,171 $202K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 5,017 4,928 $176K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 29,425 28,068 $152K
S9083 Global fee urgent care centers 1,262 1,201 $133K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 15,052 14,212 $125K
80050 General health panel 2,871 2,784 $124K
95810 Polysomnography; sleep staging with 4 or more additional parameters 399 386 $110K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 543 540 $107K
X0616 376 376 $76K
X0620 392 380 $75K
80061 Lipid panel 4,798 4,692 $64K
97161 893 888 $62K
80048 Basic metabolic panel (calcium, ionized) 7,754 7,411 $61K
70450 Computed tomography, head or brain; without contrast material 929 893 $57K
97162 782 771 $53K
71275 Computed tomographic angiography, chest, with contrast material 290 281 $50K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 858 809 $48K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 1,541 1,505 $44K
87631 316 313 $44K
74176 Computed tomography, abdomen and pelvis; without contrast material 519 503 $43K
71046 Radiologic examination, chest; 2 views 4,006 3,887 $42K
81001 13,961 13,472 $41K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) 2,881 2,835 $41K
77067 Screening mammography, bilateral, including computer-aided detection 426 416 $37K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 411 281 $35K
83690 8,019 7,743 $35K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 5,218 5,117 $35K
84443 Thyroid stimulating hormone (TSH) 1,669 1,611 $34K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences 115 113 $28K
87086 Culture, bacterial; quantitative colony count, urine 3,572 3,395 $27K
87070 3,715 3,643 $26K
95811 42 42 $22K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 975 908 $21K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 973 906 $21K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 488 470 $20K
71045 Radiologic examination, chest; single view 3,806 3,662 $20K
80081 240 233 $20K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 271 263 $19K
83735 2,744 2,598 $18K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 629 607 $17K
72125 Computed tomography, cervical spine; without contrast material 249 245 $16K
93971 269 253 $16K
84484 2,075 1,897 $15K
97164 407 401 $15K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 379 213 $14K
84702 842 666 $13K
80076 1,633 1,592 $13K
73564 732 607 $12K
97163 200 200 $12K
83880 480 457 $12K
86803 641 628 $12K
82728 1,010 976 $12K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 118 115 $11K
83036 Hemoglobin; glycosylated (A1C) 1,661 1,622 $11K
76705 Ultrasound, abdominal, real time with image documentation; limited 358 336 $11K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 515 514 $11K
82607 983 957 $10K
J1756 Injection, iron sucrose, 1 mg 2,190 912 $10K
84439 1,253 1,217 $10K
73610 642 598 $10K
77063 Screening digital breast tomosynthesis, bilateral 421 411 $9K
76770 233 228 $9K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 70 70 $9K
83970 227 219 $8K
73630 820 734 $8K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm 269 187 $8K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited 217 197 $8K
71250 143 141 $8K
72148 Magnetic resonance imaging, lumbar spine; without contrast material 54 53 $8K
71260 Computed tomography, thorax, diagnostic; with contrast material 105 104 $7K
81003 2,392 2,295 $7K
85027 1,094 1,014 $7K
76536 144 139 $7K
73030 550 501 $7K
45380 Colonoscopy, flexible; with biopsy, single or multiple 33 32 $6K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material 27 27 $6K
73502 370 348 $6K
83540 779 750 $6K
72100 371 364 $6K
84153 261 250 $6K
82570 818 780 $6K
96367 289 185 $6K
90715 541 479 $6K
93970 70 67 $6K
86003 45 45 $5K
85610 1,693 1,513 $5K
85730 1,012 955 $5K
73130 560 467 $5K
85379 565 535 $5K
81002 1,500 1,464 $5K
82784 252 246 $5K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 160 138 $5K
86480 70 68 $5K
73562 339 263 $5K
99281 Emergency department visit for the evaluation and management, self-limited or minor 128 125 $4K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 82 75 $4K
70496 28 27 $4K
73110 422 384 $4K
86618 173 164 $4K
87340 284 276 $4K
86038 270 260 $4K
70486 59 58 $4K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) 12 12 $4K
87186 537 510 $4K
82043 488 475 $4K
87077 549 521 $4K
87040 212 200 $3K
83550 696 670 $3K
72110 176 171 $3K
88305 Level IV - Surgical pathology, gross and microscopic examination 360 350 $3K
70551 Magnetic resonance imaging, brain; without contrast material 16 16 $3K
86850 400 380 $3K
93017 86 81 $3K
76801 102 96 $3K
J7030 Infusion, normal saline solution , 1000 cc 2,397 2,034 $3K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 1,064 1,027 $3K
86140 915 890 $3K
83605 415 392 $3K
97167 39 39 $3K
84403 95 95 $3K
70498 16 16 $2K
84146 99 97 $2K
85652 752 726 $2K
82746 238 229 $2K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 253 199 $2K
J1885 Injection, ketorolac tromethamine, per 15 mg 19,281 15,646 $2K
86255 122 122 $2K
73560 164 142 $2K
86901 511 480 $2K
86800 103 97 $2K
86900 511 480 $2K
82550 298 294 $2K
86592 464 453 $2K
76870 44 40 $2K
36415 Collection of venous blood by venipuncture 2,148 1,862 $2K
73590 146 132 $2K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal 29 29 $2K
83001 93 93 $2K
82948 775 647 $2K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 112 109 $1K
J3490 Unclassified drugs 1,664 934 $1K
87147 305 294 $1K
84402 53 53 $1K
73080 161 151 $1K
86430 185 176 $1K
87430 199 197 $1K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 25 24 $1K
84156 306 284 $1K
73140 171 160 $1K
72040 83 83 $1K
82950 161 158 $1K
84703 108 105 $1K
J2704 Injection, propofol, 10 mg 6,382 4,137 $995.42
86376 124 119 $994.99
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 426 376 $993.50
G0382 Level 3 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) 13 12 $965.44
84550 157 144 $947.26
81025 703 621 $933.44
J2270 Injection, morphine sulfate, up to 10 mg 1,364 1,201 $930.14
74018 88 84 $920.14
72050 43 43 $918.07
82247 127 96 $910.33
94729 39 39 $882.83
83002 55 55 $866.66
93880 14 12 $856.26
J1100 Injection, dexamethasone sodium phosphate, 1 mg 5,491 4,552 $846.90
84144 54 45 $829.26
82805 25 25 $792.74
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward 12 12 $792.00
86200 59 58 $787.32
94726 38 38 $775.92
76700 Ultrasound, abdominal, real time with image documentation; complete 14 14 $767.67
96375 Therapeutic injection; each additional sequential IV push 85 66 $729.69
84100 140 137 $710.26
J1040 Injection, methylprednisolone acetate, 80 mg 158 151 $706.14
85007 208 181 $670.36
84481 29 26 $636.66
82785 40 40 $614.25
97168 17 17 $583.92
93923 12 12 $583.42
86706 43 41 $575.13
J2405 Injection, ondansetron hydrochloride, per 1 mg 9,974 8,663 $564.37
86235 12 12 $558.00
J2765 Injection, metoclopramide hcl, up to 10 mg 2,997 2,762 $534.08
86704 38 38 $533.23
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 18 18 $505.26
J3360 Injection, diazepam, up to 5 mg 269 224 $495.89
83615 67 59 $471.07
J0696 Injection, ceftriaxone sodium, per 250 mg 897 842 $416.88
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 1,121 1,017 $373.10
J7050 Infusion, normal saline solution, 250 cc 626 234 $350.38
80143 12 12 $314.34
J1200 Injection, diphenhydramine hcl, up to 50 mg 2,600 2,266 $309.61
82553 31 31 $290.82
93226 13 13 $286.26
73090 32 32 $264.80
82105 13 13 $247.52
84145 16 16 $222.10
87205 46 45 $207.72
J1170 Injection, hydromorphone, up to 4 mg 1,329 1,076 $207.54
76830 Ultrasound, transvaginal 12 12 $176.92
82670 12 12 $176.30
94010 30 30 $163.59
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 15 13 $162.80
71101 16 16 $149.15
83655 13 13 $142.00
J3475 Injection, magnesium sulfate, per 500 mg 1,082 958 $141.28
83525 12 12 $138.60
83020 13 13 $138.60
93225 13 13 $131.40
80069 12 12 $120.57
J3010 Injection, fentanyl citrate, 0.1 mg 3,360 2,683 $116.33
82077 67 60 $109.89
80179 12 12 $108.57
J0690 Injection, cefazolin sodium, 500 mg 1,571 1,290 $102.40
84425 13 13 $91.94
J1630 Injection, haloperidol, up to 5 mg 506 453 $85.36
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 19 14 $74.44
J2060 Injection, lorazepam, 2 mg 976 842 $69.73
99152 13 13 $59.40
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 61 52 $56.71
OP250 45 27 $22.89
J2250 Injection, midazolam hydrochloride, per 1 mg 2,394 2,172 $20.77
J7120 Ringers lactate infusion, up to 1000 cc 31 24 $20.54
J1644 Injection, heparin sodium, per 1000 units 215 129 $7.68
94760 12 12 $0.35
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 167 154 $0.11
J1010 Injection, methylprednisolone acetate, 1 mg 12 12 $0.00
J2795 Injection, ropivacaine hydrochloride, 1 mg 72 68 $0.00
J2003 Injection, lidocaine hydrochloride, 1 mg 188 163 $0.00
96361 Intravenous infusion, hydration; each additional hour 13 12 $0.00
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 28 26 $0.00
J1030 Injection, methylprednisolone acetate, 40 mg 53 40 $0.00
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 1,040 826 $0.00
J1596 Injection, glycopyrrolate, 0.1 mg 56 41 $0.00
J2919 Injection, methylprednisolone sodium succinate, 5 mg 49 44 $0.00
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg 134 127 $0.00
J1171 Injection, hydromorphone, 0.1 mg 33 27 $0.00
J0136 Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg 85 81 $0.00